We found that the pharmacological inhibition of SIRT1 and SIRT2 with tenovin-6 effectively inhibited the proliferation of seven pediatric sarcoma cell lines at concentrations between 2 and 5 μM (Table 1). Here, SIRT1 is linked to sarcoma.